Oxybutynin tablets

Oxybutynin tablets

Form: Tablet(IR & ER)

Strength: IR: 5 mg, 10 mg; ER: 5 mg, 10 mg

Reference Brands: Ditropan, Oxybutynin XL(US)

Category: Multiple sclerosis

Oxybutynin IR and ER tablets, marketed as Ditropan and Ditropan XL, are approved in the US by the FDA and in the EU via EMA for overactive bladder management. Regulatory approval requires a detailed dossier containing clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. In the US, the FDA reviews clinical and quality data, while the EMA ensures compliance with regional standards. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Ensuring compliance is essential for timely approval, safe use, and global availability of oxybutynin tablets, supporting effective long-term management of bladder overactivity worldwide.

Get Enquiry Back to Listing
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.

Related Products

LamotriginevDispersible tablets

Strength: XR: 25 mg, 50 mg, 100 mg, 200 mg; IR: 25 mg, 100 mg, 200 mg, 300 mg

Form: Tablets(IR & ER)

Reference Brands: Lamictal, Lamictal XR(EU & US)

View Details Get Enquiry
Tolterodine tablets/ Capsules(IR & ER)

Strength: IR: 1 mg, 2 mg; ER: 2mg, 4 mg

Form: Tablets/ Capsules(IR & ER)

Reference Brands: Detrol, Detrol LA(US & EU)

View Details Get Enquiry
Oxybutynin tstransdermal patch

Strength: 3.9 mg/24 hours

Form: transdermal patch

Reference Brands: Oxytrol, Oxytrol for Women(US & EU)

View Details Get Enquiry
Dalfampridine

Strength: 10 mg

Form: Extended-Release tablets (XR)

Reference Brands: Ampyra(US)

View Details Get Enquiry

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.